Brave Asset Management’s QIAGEN NV QGENF Stock Holding History

Brave Asset Management’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-500	Closed	-$11K	–	461
2016 Q1	$11K	Hold	500	–	–	0.01%	344
2015 Q4	$14K	Hold	500	–	–	0.01%	326
2015 Q3	$13K	Hold	500	–	–	0.01%	315
2015 Q2	$12K	Hold	500	–	–	0.01%	351
2015 Q1	$13K	Hold	500	–	–	0.01%	347
2014 Q4	$12K	Hold	500	–	–	0.01%	354
2014 Q3	$11K	Hold	500	–	–	0.01%	352
2014 Q2	$12K	Hold	500	–	–	0.01%	349
2014 Q1	$11K	Hold	500	–	–	0.01%	352
2013 Q4	$12K	Buy	+500	New	+$12K	0.01%	339

Other funds holding QGENF

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Brave Asset Management's QGENF Position: Q2 2016 in Review

Brave Asset Management sold out of QIAGEN NV (QGENF) in Q2 2016, closing a stake of 500 shares — an estimated $11K sold.

Brave Asset Management first reported a position in QGENF in Q4 2013 and held it in 10 quarters. The position peaked at $14K in Q4 2015. 188 funds tracked by Wall St. Rank hold QGENF as of Q2 2016.

Brave Asset Management reported no remaining QIAGEN NV position as of Q2 2016 after selling out during the quarter.
Brave Asset Management sold 500 QIAGEN NV shares in Q2 2016, an estimated $11K.
Brave Asset Management first reported a position in QIAGEN NV in Q4 2013 and held it in 10 quarters.
Brave Asset Management's QIAGEN NV position peaked at $14K in Q4 2015.
188 funds tracked by Wall St. Rank held QIAGEN NV as of Q2 2016.

Based on Brave Asset Management's 13F filing for Q2 2016, filed 9 Aug 2016.